Lexicon Pharmaceuticals Inc.

07/28/2025 | Press release | Distributed by Public on 07/28/2025 05:37

Material Event (Form 8-K)

Item 8.01Other Events
On July 23, 2025, we received a letter from the Listing Qualifications staff of The NASDAQ Stock Market LLC ("Nasdaq") indicating that we have regained compliance with Nasdaq's minimum $1 bid price requirement for our common stock and that the matter relating to our previous failure to meet such requirement is now closed.
Lexicon Pharmaceuticals Inc. published this content on July 28, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on July 28, 2025 at 11:37 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]